TheEdgeResearch
Home / Stocks / ASNB

EKIMAS Corporation (ASNB)

OTC Financial Services Shell Companies
$0.85 ▲ +6.58%
Market Cap
$4.8M
Sector
Financial Services
Industry
Shell Companies
Beta
-0.58
52-Wk Range
0.55-1.7
CEO
Henrik Rouf
Country
US
Currency
USD

EKIMAS Corporation operates in the Shell Companies industry of the Financial Services sector, headquartered in Las Vegas, NV, US. The stock last traded at $0.85, up 6.58% on the session, giving a market capitalisation of $4.8M. On trailing twelve-month figures it carries a trailing P/E of -3.86, a net margin of 0.0%. Its beta of -0.58 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-3.86
Price / Sales
0.00
Price / Book
0.24
EV / EBITDA
-1.10
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
0.00
Current ratio
0.46
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
11
IPO date
1996-06-12
Headquarters
Las Vegas, NV, US
About EKIMAS Corporation

Currently, EKIMAS Corporation does not engage in significant business operations. In its earlier years, the company focused on creating specialized polymer materials used in the development of medical devices, designed to address various anatomical regions and health issues. The firm's current objective is to identify, acquire, or combine with an existing operating entity through an equity-for-equity transaction. Established in 1993, this Las Vegas, Nevada-based entity was formerly known as AdvanSource Biomaterials Corporation, changing its name to EKIMAS Corporation in March 2020.

Comparable companies

EKIMAS Corporation is most often compared with the following Financial Services names:

CDBTEATBFENGAEZRGFDOCGDVMHLCOMTRIPGIDTOGI
More research on ASNB
ASNB technical analysis ASNB TheEdge Score Compare against peers
Open full interactive analysis & DCF →